Physician profile
Matthew T Bennett
NPI 1831118199
$5,550.62
in general payments reported to CMS, 2019-2025
14 companies · $543 in 2025
The $543 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $668 · 2020: $102 · 2021: $129 · 2022: $2,361 · 2023: $777 · 2024: $972 · 2025: $543.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,291.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,291.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mml US, INC. | $3,093.86 | 2022-2025 | Reactiv8 |
| Medtronic, INC. | $887.53 | 2021-2025 | Catalyft Pl Expandable Interbody System, Cd Horizon Spinal System, Mazor X System |
| Nevro Corp. | $365.42 | 2019-2023 | Senza |
| Spr Therapeutics, INC | $219.90 | 2023-2025 | Sprint Pns System |
| Medtronic USA, INC. | $199.60 | 2019 | |
| Abbvie INC. | $192.44 | 2019 | |
| Boston Scientific Corporation | $152.78 | 2019-2025 | General - Pain Management |
| Stryker Corporation | $134.62 | 2024 | Yukon Oct Spinal System |
| Abbott Laboratories | $99.65 | 2019-2024 | Proclaim |
| Stimwave Technologies Incorporated | $58.05 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $46.66 | 2025 | |
| Scilex Pharmaceuticals INC. | $42.55 | 2020 | |
| Si-Bone, INC. | $30.83 | 2019-2020 | |
| Sentynl Therapeutics, INC. | $26.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Bennett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.